The efficacy and safety of the high‐intensity parallel beam ultrasound device at the depth of 1.5 mm for skin tightening
Journal of Cosmetic Dermatology · 2023-05 · 22 (5) · 1488-1494
DOI: 10.1111/jocd.15672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 09.02.2023. Verfasst von Wichai Hongcharu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Wichai Clinic, Bangkok, Thailand. Hauptthemen laut MEDLINE: Cosmetic Techniques, Skin Aging, Ultrasonic Therapy. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
High‐intensity parallel beam ultrasound (US) is a novel device equipped with Synchronous Ultrasound Parallel Beam (SUPERB) technology applied in anti‐aging treatment. The system is aimed at pathways stimulating neocollagenesis and neoelastinogenesis in the dermis leading to skin tightening and rejuvenation.
Aims
Evaluate the efficacy and safety of the high‐intensity parallel beam US device at the depth of 1.5 mm for skin tightening treatment.
Methods
Thirty‐six participants were enrolled in the study. Digital photographs and Antera 3D photographs were taken at baseline, 1 and 3 months post‐treatment. The depression volume of nasolabial folds (NLFs) and marionette lines (MLs) in each visit was evaluated using Antera 3D imaging program. Pain was evaluated by pain measurement scales immediately after treatment. Any procedure related side effects were documented and examined.
Results
Post‐treatment results were compared to the baseline; statistically significant mean depression volume (MDV) change of NLFs and MLs were found at 1 and 3 months post‐treatment. No significant MDV change from 1 to 3 months post‐treatment could be demonstrated. The mean pain score was 6.64 on a 0–10 scale. No adverse events were reported.
Conclusions
Our study demonstrates that the novel high‐intensity parallel beam US device is clinically safe and effective for skin tightening in the lower face area. We noticed a reduction in NLFs and MLs in more than 60% of our participants already as early as 1 month post‐treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dr. Wichai Clinic, Bangkok, Thailand.
- Gold Skin Care Center, Nashville, Tennessee, USA.
- The Tennessee Clinical Research Center, Nashville, Tennessee, USA.
ORCID-Profile: Wichai Hongcharu, Michael H Gold
Zitieren
APA
Hongcharu, W., Boonchoo, K., & Gold, M. H. (2023). The efficacy and safety of the high‐intensity parallel beam ultrasound device at the depth of 1.5 mm for skin tightening. Journal of Cosmetic Dermatology, 22(5), 1488-1494. https://doi.org/10.1111/jocd.15672
Vancouver
Hongcharu W, Boonchoo K, Gold MH. The efficacy and safety of the high‐intensity parallel beam ultrasound device at the depth of 1.5 mm for skin tightening. Journal of Cosmetic Dermatology. 2023;22(5):1488-1494. doi:10.1111/jocd.15672
BibTeX
@article{Hongcharu2023,
author = {Hongcharu, Wichai and Boonchoo, Kanjana and Gold, Michael H},
title = {The efficacy and safety of the high‐intensity parallel beam ultrasound device at the depth of 1.5 mm for skin tightening},
journal = {Journal of Cosmetic Dermatology},
year = {2023},
volume = {22},
number = {5},
pages = {1488--1494},
doi = {10.1111/jocd.15672}
}
EUVIMED